![Sample our Behavioral Sciences journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110801/TOC-Subject-Sample-2021-Behavioral-Sciences.jpg"})
Disclaimer
The opinions expressed in this editorial are strictly those of the author.
Financial & competing interests disclosure
DG Stein has been conducting preclinical research on progesterone as a treatment for brain injury for more than 25 years. DG Stein holds patents on the use of progesterone for traumatic brain injury and other forms of brain injury, although none of this technology is currently licensed. No fees or royalties are currently obtained from the research although the author does receive occasional honoraria for colloquia and scientific workshops presented on this topic. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.